China National Accord Medicines Corporation Ltd. (000028.SZ) SHZ

Currency In CNY

AD

China National Accord Medicines Corporation Ltd.

Address

Accord Pharm. Building

Shenzhen, GD 518029

China

Phone

86 755 2587 5140

Sector

Healthcare

Industry

Medical - Distribution

Employees

39449

First IPO Date

June 08, 1993

Key Executives

NameTitlePayYear Born
Chuan LiDeputy GM & Board Secretary01977
Zhaoxiong LinGM & Non-Independent Director01967
Guolin GuDeputy GM, CFO, General Counsel & Chief Compliance Officer01976
Baochun LangGeneral Counsel, Chief Legal Counsel & Chairman of the Trade Union01964
Changbing ChenDeputy General Manager01968
Jinxiong LiGM & Non-Independent Director01979
Xuefei WangAccounting Supervisor0N/A
AD

Description

China National Accord Medicines Corporation Ltd. primarily focuses on the wholesale and retail distribution of a wide array of pharmaceutical and medical products. The company's extensive product offerings include traditional Chinese remedies, advanced biochemical and biological medicines, diagnostic agents, and antibiotics. Additionally, it supplies various chemical preparations, food items, industrial chemicals, and a diverse range of other general commodities. Beyond its core sales activities, the company is involved in selling medical apparatus and instruments. It offers comprehensive logistics services, encompassing freight transportation, warehousing, and cargo handling, alongside professional consulting. Further diversifying its operations, it markets glassware, cosmetics, and daily necessities, and provides goods agency services. The firm also participates in the import and export of technology, leases properties, and engages in the wholesale and retail of health-related products. As of December 31, 2021, China National Accord Medicines managed a significant network of 8,798 drugstores across 20 provinces, autonomous regions, and municipalities within China. This expansive retail footprint included 7,257 directly owned stores and 1,541 franchised locations. Established in 2004 and based in Shenzhen, China, the company operates as a subsidiary of Sinopharm Group Co., Ltd.

AD